ESC Congress 2016

27 - 31 August 2016, Rome - Italy

Session Details

Hot Line prevention and lipids
Mon 29 Aug 11:00 - 12:30 Miscellaneous Hot Line Rome - Main Auditorium
Chairpersons: Diederick E GROBBEE (Utrecht, Netherlands), Issei KOMURO (Tokyo, Japan)

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
11:003157HIJ-PROPER - LDL cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidemiaNobuhisa HAGIWARA (Tokyo, Japan)
11:103158HIJ-PROPER - Discussant review.Stephan GIELEN (Detmold, Germany)
11:153159HIJ-PROPER - Panel discussion. 
11:183160OPTICARE - Benefits of the OPTImal CArdiac REhabilitation trial: a randomized, controlled superiority trial of an expanded educational and behavioral interventionRon T VAN DOMBURG (Rotterdam, Netherlands)
11:283161OPTICARE - Discussant review.Ana ABREU (Lisboa, Portugal)
11:333162OPTICARE - Panel discussion. 
11:363163A naturally randomized trial comparing the effect of long-term exposure to lower LDL-C, lower SBP, or both on the risk of cardiovascular diseaseBrian A FERENCE (Plymouth, United States of America)
11:463164A naturally randomized trial comparing the effect of long-term exposure to lower LDL-C, lower SBP, or both on the risk of cardiovascular disease - Discussant review.Thierry GILLEBERT (Boechout, Belgium)
11:513165A naturally randomized trial comparing the effect of long-term exposure to lower LDL-C, lower SBP, or both on the risk of cardiovascular disease - Panel discussion. 
11:543166ESCAPE - Effect of alirocumab on the frequency of lipoprotein apheresis: a randomised Phase III trialPatrick MORIARTY (Kansas City, United States of America)
12:043167ESCAPE - Discussant review.Eric BRUCKERT (Paris, France)
12:093168ESCAPE - Panel discussion. 
12:123169Apheresis as a novel treatment for refractory angina with raised lipoprotein(a): a randomised controlled trialTina Zubaida KHAN (London, United Kingdom)
12:223170Apheresis as a novel treatment for refractory angina with raised lipoprotein(a) - Discussant review.Peter LIBBY (Boston, United States of America)
12:273171Apheresis as a novel treatment for refractory angina with raised lipoprotein(a) - Panel discussion.